The abstract is read at the publisher; the summary is JClub's.
Compound 9787 reduces mycobacterial mistranslation by targeting 30S ribosomal protein S5, improving translational fidelity without measurably slowing overall protein synthesis.
- Why it matters: Antibiotic tolerance in mycobacteria is linked to high basal mistranslation, but how drugs that raise fidelity work mechanistically—and whether they impose a speed cost—remains unclear.
- What they did: The team screened 9,000 synthetic compounds, optimized benzo[d]isoxazole-4,7-diones to 9787, and used competitive chemical proteomics to identify RpS5 as the cellular target.
- The result: At concentrations that did not measurably affect protein synthesis rate, 9787 enhanced translational fidelity and reversed rifampicin tolerance, suggesting ribosomal quality control is druggable without a fitness cost.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.